NCCN Guidelines for Patients® | Malignant Pleural Mesothelioma - page 52

52
NCCN Guidelines for Patients
®
: Malignant Pleural Mesothelioma
Version 1.2012
NCCN Panel Members for Malignant Pleural Mesothelioma
David S. Ettinger, MD
The Sidney Kimmel
Comprehensive Cancer
Center at Johns Hopkins
Lee M. Krug, MD
Memorial Sloan-Kettering
Cancer Center
Wallace Akerley, MD
Huntsman Cancer Institute
at the University of Utah
Hossein Borghaei, DO, MS
Fox Chase Cancer Center
Andrew C. Chang, MD
University of Michigan
Comprehensive Cancer Center
Richard T. Cheney, MD
Roswell Park Cancer Institute
Lucian R. Chirieac, MD
Dana-Farber/Brigham and
Women’s Cancer Center
Thomas A. D’Amico, MD
Duke Cancer Institute
Todd L. Demmy, MD
Roswell Park Cancer Institute
Ramaswamy Govindan, MD
Siteman Cancer Center
at Barnes-Jewish Hospital
and Washington University
School of Medicine
Frederic W. Grannis, Jr., MD
City of Hope Comprehensive
Cancer Center
Stefan C. Grant, MD, JD
University of Alabama at
Birmingham Comprehensive
Cancer Center
Leora Horn, MD, MSc, FRCPC
Vanderbilt-Ingram Cancer Center
Thierry M. Jahan, MD
UCSF Helen Diller Family
Comprehensive Cancer Center
Melissa Johnson, MD
Robert H. Lurie Comprehensive
Cancer Center of Northwestern
University
Ritsuko Komaki, MD
The University of Texas
MD Anderson Cancer Center
Feng-Ming (Spring) Kong, MD, PhD,
MPH
University of Michigan
Comprehensive Cancer Center
Mark G. Kris, MD
Memorial Sloan-Kettering
Cancer Center
Rudy P. Lackner, MD
UNMC Eppley Cancer Center at
The Nebraska Medical Center
Inga T. Lennes, MD
Massachusetts General Hospital
Cancer Center
Billy W. Loo, Jr., MD, PhD
Stanford Cancer Institute
Renato Martins, MD, MPH
Fred Hutchinson Cancer
Research Center/Seattle
Cancer Care Alliance
1...,42,43,44,45,46,47,48,49,50,51 53,54,55,56,57,58,59,60
Powered by FlippingBook